A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects
Status:
Completed
Trial end date:
2019-10-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of molidustat in
non-dialysis subjects with renal anemia who are not treated with Erythropoiesis-Stimulating
Agents (ESAs).